Type 2 Continuous Glucose Monitoring Academy
Recruiting · NCT06516640 · Interventional (participants receive a specific treatment) · Lead sponsor: Children's Hospital Los Angeles
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
The goal of this clinical trial is to evaluate the Impact of Continuous Glucose Monitoring Academy Education Curriculum Versus Standard Care on Glycemic Outcomes for Youth With Type 2 Diabetes (T2D): * The first aim is to determine how feasible it is to adapt the Continuous Glucose Monitoring Academy curriculum to teach youth with T2D glucose management strategies. * The second aim is to evaluate the effects of the Continuous Glucose Monitoring Academy metrics. * The third aim is to explore the relationships between these metrics with diabetes distress, diabetes family responsibilities, and process metrics. Participants will join for a total of four weeks of education, followed by a six-month clinical review. They will have access to an online workbook and videos, and will participate in virtual sessions with a diabetes educator who will cover glucose management strategies in-depth. Participants will wear their preferred Continuous Glucose Monitoring system (Dexcom or FreeStyle Libre) provided via insurance and inserted at the baseline visit.
Who can take part
Inclusion criteria
- Current age of 8-21 years;
- T2D diagnosis;
- Able to speak, read, and write English or Spanish
Exclusion criteria
- a. Known history of medical adhesive allergies;
Where it is running
1 location listed across 1 US state.
- Children's Hospital Los Angeles - Los Angeles, California, United States